rs201091809
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 5P and 4B. PVS1_StrongPP5BS2
The NM_015375.3(DSTYK):c.654+1G>A variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000367 in 1,602,522 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_015375.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DSTYK | NM_015375.3 | c.654+1G>A | splice_donor_variant, intron_variant | ENST00000367162.8 | NP_056190.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DSTYK | ENST00000367162.8 | c.654+1G>A | splice_donor_variant, intron_variant | 1 | NM_015375.3 | ENSP00000356130.3 | ||||
DSTYK | ENST00000367161.7 | c.654+1G>A | splice_donor_variant, intron_variant | 1 | ENSP00000356129.3 |
Frequencies
GnomAD3 genomes AF: 0.000283 AC: 43AN: 152116Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000278 AC: 68AN: 244538Hom.: 0 AF XY: 0.000303 AC XY: 40AN XY: 131984
GnomAD4 exome AF: 0.000376 AC: 545AN: 1450288Hom.: 0 Cov.: 31 AF XY: 0.000397 AC XY: 286AN XY: 719784
GnomAD4 genome AF: 0.000282 AC: 43AN: 152234Hom.: 0 Cov.: 32 AF XY: 0.000282 AC XY: 21AN XY: 74430
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 23 Pathogenic:1
Pathogenic, criteria provided, single submitter | research | Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL) | Apr 27, 2023 | - - |
Congenital anomalies of kidney and urinary tract 1 Uncertain:1
Uncertain significance, no assertion criteria provided | literature only | OMIM | Aug 15, 2013 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 04, 2022 | This sequence change affects a donor splice site in intron 2 of the DSTYK gene. RNA analysis indicates that disruption of this splice site induces altered splicing and likely results in the loss of 9 amino acid residue(s), but is expected to preserve the integrity of the reading-frame. This variant is present in population databases (rs201091809, gnomAD 0.09%), and has an allele count higher than expected for a pathogenic variant. Disruption of this splice site has been observed in individual(s) with congenital abnormalities of the kidney and urinary tract (PMID: 23862974). ClinVar contains an entry for this variant (Variation ID: 60684). Studies have shown that disruption of this splice site results in the activation of a cryptic splice site in exon 2 (PMID: 23862974). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
DSTYK-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 23, 2024 | The DSTYK c.654+1G>A variant is predicted to disrupt the GT donor site and interfere with normal splicing. This variant was reported in at least seven individuals from a single family with renal hypodysplasia, ureteropelvic junction obstruction and vesicoureteral reflux, as well as two unaffected family members and several family members with unknown phenotype (Sanna-Cherchi et al 2013. PubMed ID: 23862974). This variant has also been reported in the heterozygous state in a patient with branchiootorenal syndrome features but normal renal ultrasound, and incomplete penetrance was suggested (Heidet et al 2017. PubMed ID: 28566479). This variant is reported in 0.081% of alleles in individuals of Latino descent in gnomAD. Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at